Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Last Close
Feb 12  •  04:00PM ET
17.51
Dollar change
-1.64
Percentage change
-8.56
%
Feb 12, 6:37 PM10x Genomics beats Q4 guidance, reporting $166M revenue and a narrowed $16.3M net loss, and reinstates a cautious 2026 outlook guiding $600–$625M in revenue (flat-to-low growth, up to ~4% excluding prior-year litigation-related revenue).
IndexRUT P/E- EPS (ttm)-0.62 Insider Own11.35% Shs Outstand116.46M Perf Week-1.07%
Market Cap2.22B Forward P/E- EPS next Y-0.72 Insider Trans-0.50% Shs Float112.18M Perf Month-14.67%
Enterprise Value1.82B PEG- EPS next Q-0.29 Inst Own97.91% Short Float14.55% Perf Quarter5.55%
Income-76.32M P/S3.45 EPS this Y-168.86% Inst Trans3.76% Short Ratio6.38 Perf Half Y29.03%
Sales641.81M P/B2.82 EPS next Y23.14% ROA-7.77% Short Interest16.32M Perf YTD7.36%
Book/sh6.20 P/C4.60 EPS next 5Y-12.08% ROE-10.12% 52W High23.56 -25.68% Perf Year45.92%
Cash/sh3.81 P/FCF30.34 EPS past 3/5Y-42.17% -36.10% ROIC-8.86% 52W Low6.78 158.26% Perf 3Y-59.67%
Dividend Est.- EV/EBITDA- Sales past 3/5Y7.59% 19.96% Gross Margin71.31% Volatility6.21% 6.07% Perf 5Y-91.11%
Dividend TTM- EV/Sales2.84 EPS Y/Y TTM59.18% Oper. Margin-21.94% ATR (14)1.16 Perf 10Y-
Dividend Ex-Date- Quick Ratio4.06 Sales Y/Y TTM1.92% Profit Margin-11.89% RSI (14)38.61 Recom2.53
Dividend Gr. 3/5Y- - Current Ratio4.48 EPS Q/Q26.07% SMA20-13.99% Beta2.24 Target Price18.40
Payout- Debt/Eq0.11 Sales Q/Q-1.75% SMA50-6.22% Rel Volume1.44 Prev Close19.15
Employees1306 LT Debt/Eq0.10 EarningsFeb 12 AMC SMA20025.25% Avg Volume2.56M Price17.51
IPOSep 12, 2019 Option/ShortYes / Yes EPS/Sales Surpr.35.90% 3.99% Trades Volume3,677,057 Change-8.56%
Date Action Analyst Rating Change Price Target Change
Dec-11-25Downgrade Citigroup Buy → Neutral
Dec-02-25Downgrade Morgan Stanley Overweight → Equal-Weight $20
Sep-11-25Initiated Piper Sandler Neutral $15
Feb-13-25Downgrade Leerink Partners Outperform → Market Perform $25 → $12
Sep-03-24Initiated Leerink Partners Outperform $35
Jul-22-24Upgrade Jefferies Hold → Buy $24
Jul-18-24Downgrade JP Morgan Overweight → Neutral $40 → $20
Jul-10-24Downgrade Deutsche Bank Buy → Hold $55 → $25
Jun-27-24Downgrade Wolfe Research Outperform → Peer Perform
Jun-25-24Downgrade Guggenheim Buy → Neutral
Today 12:04AM
Feb-12-26 09:07PM
06:30PM
05:30PM
04:54PM
04:30PM Loading…
04:30PM
04:05PM
Feb-10-26 10:07PM
Feb-05-26 10:00AM
Feb-04-26 09:00AM
Jan-30-26 02:48PM
Jan-22-26 04:05PM
03:47AM
Jan-21-26 04:58PM
09:53AM
12:05AM Loading…
Jan-20-26 12:05AM
Jan-19-26 01:27PM
Jan-18-26 11:40PM
Jan-12-26 04:05PM
09:11AM
09:10AM
09:00AM
Jan-11-26 12:00PM
Jan-07-26 07:05AM
Jan-02-26 01:45PM
Dec-29-25 04:05PM
Dec-22-25 10:20PM
11:56AM
Dec-17-25 11:22AM
Dec-16-25 09:07AM
11:30AM Loading…
Dec-15-25 11:30AM
Dec-11-25 11:41AM
Dec-07-25 10:32PM
Dec-02-25 09:34AM
Nov-18-25 11:02PM
09:00AM
Nov-15-25 11:42PM
Nov-13-25 12:33AM
Nov-11-25 04:05PM
12:51PM
12:26PM
07:29AM
Nov-07-25 04:06PM
09:26AM
06:36AM
Nov-06-25 07:00PM
05:55PM
04:57PM
04:52PM
04:05PM
Nov-05-25 05:41AM
Nov-04-25 10:17PM
Oct-30-25 10:00AM
Oct-29-25 01:39PM
09:00AM
Oct-21-25 05:19AM
Oct-20-25 12:30PM
11:35AM
11:23AM
10:10AM
09:03AM
Oct-17-25 11:05AM
Oct-16-25 12:00PM
Oct-15-25 02:01PM
Oct-10-25 03:51PM
Oct-09-25 04:05PM
Sep-16-25 12:33AM
Sep-12-25 02:25PM
Sep-11-25 11:56AM
Sep-09-25 08:44AM
Aug-27-25 04:05PM
Aug-24-25 11:34PM
Aug-22-25 12:04AM
Aug-20-25 12:37AM
Aug-19-25 09:00AM
Aug-14-25 01:35AM
12:45AM
Aug-12-25 10:03AM
Aug-11-25 09:37AM
07:41AM
Aug-08-25 12:21PM
04:45AM
Aug-07-25 06:30PM
05:35PM
04:33PM
04:05PM
04:04PM
Aug-06-25 12:00PM
Aug-05-25 11:09PM
Aug-01-25 03:00PM
Jul-29-25 12:02AM
Jul-24-25 12:52PM
Jul-17-25 09:00AM
Jul-15-25 09:20AM
Jul-10-25 04:05PM
Jun-23-25 11:34PM
01:39AM
Jun-10-25 06:23AM
May-29-25 09:55AM
May-23-25 07:41AM
10X Genomics, Inc. is a life science technology company, which engages in building products to interrogate, understand and master biology. Its integrated solutions include single cell transcriptomics, single cell genomics, single cell epigenomes, linked-reads genomics and spatial transcriptomics. The company's products include Single Cell Gene Expression, Immune Profiling, ATAC, and Genome. The company was founded by Serge Saxonov, Ben Hindson and Kevin D. Ness on July 2, 2012 and is headquartered in Pleasanton, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Saxonov SergeChief Executive OfficerJan 05 '26Option Exercise1.2050,00060,0001,071,556Jan 07 04:52 PM
Taich AdamChief Financial OfficerNov 24 '25Sale19.0011,888225,852297,385Nov 25 05:24 PM
Hindson Benjamin J.See RemarksNov 24 '25Sale19.008,283157,363432,605Nov 25 05:24 PM
Saxonov SergeChief Executive OfficerNov 24 '25Sale19.0013,261251,9361,021,556Nov 25 05:23 PM
Hindson Benjamin J.OfficerNov 24 '25Proposed Sale18.347,392135,569Nov 24 05:32 PM
Saxonov SergeOfficerNov 24 '25Proposed Sale18.3413,096240,181Nov 24 04:56 PM
Taich AdamOfficerNov 24 '25Proposed Sale18.3411,312207,462Nov 24 04:28 PM
Saxonov SergeChief Executive OfficerAug 22 '25Sale13.799,348128,881945,892Aug 26 04:15 PM
Taich AdamChief Financial OfficerAug 22 '25Sale13.7922,315307,657309,273Aug 26 04:14 PM
Hindson Benjamin J.See RemarksAug 22 '25Sale13.797,486103,209440,888Aug 26 04:12 PM
Saxonov SergeOfficerAug 22 '25Proposed Sale13.419,228123,747Aug 22 04:26 PM
Hindson Benjamin J.OfficerAug 22 '25Proposed Sale13.417,39399,140Aug 22 04:21 PM
Taich AdamOfficerAug 22 '25Proposed Sale13.4122,037295,516Aug 22 04:17 PM
Saxonov SergeChief Executive OfficerMay 22 '25Sale8.309,34377,5401,083,625May 27 05:08 PM
Hindson Benjamin J.See RemarksMay 22 '25Sale8.307,48562,120448,374May 27 05:07 PM
Taich AdamChief Financial OfficerMay 22 '25Sale8.304,04433,562331,588May 27 05:06 PM
Hindson Benjamin J.OfficerMay 22 '25Proposed Sale9.087,39267,119May 22 04:44 PM
Taich AdamOfficerMay 22 '25Proposed Sale9.083,99436,266May 22 04:36 PM
Saxonov SergeOfficerMay 22 '25Proposed Sale9.089,22783,781May 22 04:24 PM
Saxonov SergeChief Executive OfficerMar 04 '25Option Exercise1.2050,00060,000921,540Mar 04 06:50 PM
Saxonov SergeChief Executive OfficerFeb 28 '25Sale10.637,94284,393871,540Mar 04 06:50 PM
Serge SaxonovDirector, CEOFeb 28 '25Proposed Sale10.577,94283,947Feb 28 05:03 PM
Hindson Benjamin J.See RemarksFeb 24 '25Sale11.074,57350,603335,324Feb 26 05:43 PM
Saxonov SergeChief Executive OfficerFeb 24 '25Sale11.075,09256,346879,482Feb 26 05:42 PM
MATEO ALANDirectorFeb 21 '25Buy11.1440,000445,57261,691Feb 25 05:22 PM
Saxonov SergeOfficerFeb 24 '25Proposed Sale11.565,10459,002Feb 24 08:01 PM
Hindson Benjamin J.OfficerFeb 24 '25Proposed Sale11.564,56352,748Feb 24 07:35 PM
Last Close
Feb 12  •  04:00PM ET
171.99
Dollar change
-5.05
Percentage change
-2.85
%
VEEV Veeva Systems Inc daily Stock Chart
Index- P/E33.42 EPS (ttm)5.15 Insider Own8.78% Shs Outstand164.34M Perf Week-6.45%
Market Cap28.27B Forward P/E20.03 EPS next Y8.59 Insider Trans-0.18% Shs Float149.94M Perf Month-24.73%
Enterprise Value21.72B PEG1.42 EPS next Q1.93 Inst Own85.74% Short Float3.34% Perf Quarter-42.50%
Income860.33M P/S9.18 EPS this Y20.30% Inst Trans-1.41% Short Ratio2.62 Perf Half Y-38.39%
Sales3.08B P/B4.01 EPS next Y8.16% ROA11.83% Short Interest5.01M Perf YTD-22.95%
Book/sh42.84 P/C4.26 EPS next 5Y14.08% ROE13.72% 52W High310.50 -44.61% Perf Year-26.29%
Cash/sh40.38 P/FCF20.93 EPS past 3/5Y17.95% 17.84% ROIC12.08% 52W Low175.13 -1.79% Perf 3Y2.00%
Dividend Est.- EV/EBITDA23.07 Sales past 3/5Y14.06% 19.99% Gross Margin75.40% Volatility4.66% 3.98% Perf 5Y-45.92%
Dividend TTM- EV/Sales7.05 EPS Y/Y TTM27.91% Oper. Margin28.88% ATR (14)8.17 Perf 10Y726.08%
Dividend Ex-Date- Quick Ratio7.53 Sales Y/Y TTM15.96% Profit Margin27.93% RSI (14)20.11 Recom1.82
Dividend Gr. 3/5Y- - Current Ratio7.53 EPS Q/Q24.15% SMA20-15.51% Beta1.09 Target Price308.70
Payout0.00% Debt/Eq0.01 Sales Q/Q16.02% SMA50-21.34% Rel Volume1.65 Prev Close177.04
Employees7291 LT Debt/Eq0.01 EarningsNov 20 AMC SMA200-34.29% Avg Volume1.91M Price171.99
IPOOct 16, 2013 Option/ShortYes / Yes EPS/Sales Surpr.4.52% 2.33% Trades Volume3,152,454 Change-2.85%
Date Action Analyst Rating Change Price Target Change
Jan-13-26Resumed Goldman Sell $215
Jan-08-26Upgrade Truist Hold → Buy
Dec-12-25Downgrade KeyBanc Capital Markets Overweight → Sector Weight
Nov-13-25Initiated BMO Capital Markets Market Perform $300
Oct-07-25Upgrade TD Cowen Hold → Buy $380
Sep-08-25Upgrade JP Morgan Neutral → Overweight $330
May-29-25Reiterated Needham Buy $270 → $300
Jan-23-25Downgrade Goldman Buy → Sell $261 → $200
Dec-20-24Initiated Stephens Overweight $280
Dec-04-24Initiated Mizuho Outperform $275
Feb-12-26 09:00AM
Feb-11-26 04:05PM
Feb-10-26 05:45PM
11:12AM
Feb-08-26 04:27AM
07:06AM Loading…
Feb-06-26 07:06AM
Feb-04-26 12:15PM
11:55AM
07:03AM
Feb-03-26 09:45AM
09:30AM
Feb-02-26 07:46PM
12:35PM
09:42AM
Jan-30-26 08:28AM
11:39PM Loading…
Jan-29-26 11:39PM
05:45PM
08:00AM
Jan-28-26 09:00AM
Jan-27-26 07:03AM
Jan-23-26 05:45PM
Jan-22-26 05:50PM
Jan-16-26 05:45PM
Jan-15-26 09:45AM
Jan-14-26 11:31PM
09:00AM
Jan-13-26 09:30AM
08:29AM
Jan-12-26 05:50PM
Jan-11-26 10:36PM
08:30AM Loading…
Jan-09-26 08:30AM
Jan-08-26 04:05PM
08:30AM
07:03AM
Jan-07-26 11:57AM
11:25AM
07:03AM
Jan-06-26 03:05PM
01:51PM
Jan-05-26 04:35PM
Jan-02-26 10:48AM
Dec-31-25 11:31PM
Dec-29-25 11:42AM
Dec-23-25 08:52AM
Dec-22-25 09:53AM
Dec-19-25 09:45AM
Dec-17-25 11:34PM
Dec-12-25 04:33PM
11:19AM
09:35AM
Dec-11-25 09:00AM
07:56AM
Dec-10-25 07:37AM
Dec-09-25 09:28PM
02:38PM
11:21AM
Dec-08-25 12:16PM
Dec-04-25 04:05PM
Dec-03-25 09:45AM
07:03AM
Dec-02-25 04:26AM
Dec-01-25 11:37PM
Nov-27-25 09:00AM
Nov-24-25 09:15AM
07:03AM
Nov-21-25 05:15PM
04:36PM
04:32PM
04:16PM
03:27PM
01:28PM
12:35PM
11:57AM
10:53AM
10:20AM
09:44AM
09:09AM
08:31AM
07:36AM
12:01AM
Nov-20-25 09:13PM
06:00PM
05:20PM
04:43PM
04:25PM
04:20PM
04:05PM
11:08AM
03:58AM
Nov-18-25 10:03PM
09:30AM
Nov-17-25 09:15AM
Nov-15-25 11:42PM
Nov-14-25 05:00PM
Nov-13-25 05:45PM
10:00AM
09:00AM
07:45AM
06:30AM
Nov-12-25 11:34PM
Veeva Systems, Inc. engages in the provision of industry cloud solutions for the global life sciences industry. Its solutions enable pharmaceutical and other life sciences companies to realize the benefits of modern cloud-based architectures and mobile applications for their most critical business functions, without compromising industry-specific functionality or regulatory compliance. The firm's customer relationship management solutions enable its customers to increase the productivity and compliance of their sales and marketing functions. Its regulated content management and collaboration solutions enable its customers to more efficiently manage regulated, content-centric processes across the enterprise. The company's customer master solution enables customers to more effectively manage complex healthcare provider and healthcare organization data. The company was founded by Mark Armenante, Peter P. Gassner, Doug Ostler, Mitch Wallace and Matthew J. Wallach on January 12, 2007, and is headquartered in Pleasanton, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Schwenger Thomas D.Pres. & Chief Customer OfficerJan 13 '26Sale231.431,000231,43023,204Jan 15 04:43 PM
THOMAS SCHWENGEROfficerJan 13 '26Proposed Sale233.213,000699,630Jan 13 04:23 PM
Faddis JonathanSVP, Gen. Counsel, SecretaryJan 01 '26Option Exercise0.001,22504,092Jan 05 04:26 PM
Van Wagener BrianChief Financial OfficerJan 01 '26Option Exercise0.0087108,202Jan 05 04:25 PM
Zuppas Eleni NitsaPresident & Chief of StaffJan 01 '26Option Exercise0.001,498026,823Jan 05 04:24 PM
Schwenger Thomas D.Pres. & Chief Customer OfficerJan 01 '26Option Exercise0.002,042024,835Jan 05 04:23 PM
Kondath VipinChief Accounting OfficerJan 01 '26Option Exercise0.0010301,073Jan 05 04:22 PM
SEKHRI PAUL JDirectorDec 01 '25Option Exercise0.00254017,176Dec 03 10:04 AM
Cabral Timothy SDirectorDec 01 '25Option Exercise0.002630525Dec 02 02:00 PM
Carges Mark TDirectorDec 01 '25Option Exercise0.002710542Dec 02 01:59 PM
Ritter GordonDirectorDec 01 '25Option Exercise0.0029801,393Dec 02 01:57 PM
Wallach Matthew JDirectorDec 01 '25Option Exercise0.002540106,427Dec 02 01:56 PM
Hedley Mary LynneDirectorDec 01 '25Option Exercise0.0026306,628Dec 02 01:54 PM
Hung PriscillaDirectorDec 01 '25Option Exercise0.0026304,491Dec 02 01:52 PM
MOHR MARSHALLDirectorDec 01 '25Option Exercise0.0028905,399Dec 02 01:50 PM
Zuppas Eleni NitsaPresident & Chief of StaffOct 07 '25Option Exercise135.496,000812,94031,325Oct 09 11:34 AM
Zuppas Eleni NitsaPresident & Chief of StaffOct 07 '25Sale306.626,0001,839,69425,325Oct 09 11:34 AM
Faddis JonathanSVP, Gen. Counsel, SecretaryOct 06 '25Sale298.12720214,6467,868Oct 08 02:29 PM
ELENI NITSA A ZUPPASOfficerOct 07 '25Proposed Sale306.626,0001,839,694Oct 07 05:50 PM
Faddis JonathanOfficerOct 06 '25Proposed Sale298.12720214,646Oct 06 04:13 PM
DIAMOND KRISTINEChief Accounting OfficerOct 01 '25Option Exercise0.0021801,221Oct 03 04:40 PM
Van Wagener BrianChief Financial OfficerOct 01 '25Option Exercise0.0087207,605Oct 03 04:39 PM
Zuppas Eleni NitsaPresident & Chief of StaffOct 01 '25Option Exercise0.001,498026,086Oct 03 04:37 PM
Schwenger Thomas D.Pres. & Chief Customer OfficerOct 01 '25Option Exercise0.002,043028,017Oct 03 04:36 PM
Schwenger Thomas D.Pres. & Chief Customer OfficerOct 02 '25Sale300.043,3501,005,14023,773Oct 03 04:36 PM
Faddis JonathanSVP, Gen. Counsel, SecretaryOct 02 '25Option Exercise197.7314,5952,885,84518,000Oct 03 04:33 PM
Faddis JonathanSVP, Gen. Counsel, SecretaryOct 01 '25Option Exercise0.001,22609,128Oct 03 04:33 PM
Faddis JonathanSVP, Gen. Counsel, SecretaryOct 02 '25Sale300.0014,5954,378,5008,588Oct 03 04:33 PM
Faddis JonathanOfficerOct 02 '25Proposed Sale300.0014,5954,378,500Oct 02 05:35 PM
Schwenger Thomas D.OfficerOct 02 '25Proposed Sale300.043,3501,005,139Oct 02 05:06 PM
Cabral Timothy SDirectorSep 01 '25Option Exercise0.002620262Sep 03 07:13 PM
Carges Mark TDirectorSep 01 '25Option Exercise0.002710271Sep 03 07:12 PM
Hung PriscillaDirectorSep 01 '25Option Exercise0.0026204,228Sep 03 07:10 PM
Hedley Mary LynneDirectorSep 01 '25Option Exercise0.0026206,365Sep 03 07:09 PM
MOHR MARSHALLDirectorSep 01 '25Option Exercise0.0028905,110Sep 03 07:07 PM
SEKHRI PAUL JDirectorSep 01 '25Option Exercise0.00253016,922Sep 03 07:04 PM
Ritter GordonDirectorSep 01 '25Option Exercise0.0029801,095Sep 03 06:53 PM
Wallach Matthew JDirectorSep 01 '25Option Exercise0.002530106,173Sep 03 06:48 PM
Faddis JonathanSVP, Gen. Counsel, SecretaryJul 10 '25Sale285.62720205,6467,902Jul 11 05:27 PM
Faddis JonathanOfficerJul 10 '25Proposed Sale285.62720205,646Jul 10 04:21 PM
Hung PriscillaDirectorJul 03 '25Sale283.0017248,6764,137Jul 08 05:12 PM
Hung PriscillaDirectorJul 07 '25Sale284.4017148,6323,966Jul 08 05:12 PM
PRISCILLA HUNGDirectorJul 03 '25Proposed Sale282.6134396,935Jul 03 01:23 PM
Van Wagener BrianChief Financial OfficerJul 01 '25Option Exercise0.0087207,007Jul 02 07:31 PM
DIAMOND KRISTINEChief Accounting OfficerJul 01 '25Option Exercise0.0021801,082Jul 02 07:30 PM
Schwenger Thomas D.Pres. & Chief Customer OfficerJul 01 '25Option Exercise0.002,043026,782Jul 02 06:36 PM
Zuppas Eleni NitsaPresident & Chief of StaffJul 01 '25Option Exercise0.001,498025,127Jul 02 06:34 PM
Faddis JonathanSVP, Gen. Counsel, SecretaryJul 01 '25Option Exercise0.001,22609,061Jul 02 04:57 PM
Cabral Timothy SDirectorJun 06 '25Sale289.7231591,2625,500Jun 09 04:48 PM
Cabral Timothy SDirectorJun 06 '25Proposed Sale289.4831591,187Jun 06 11:49 AM
Cabral Timothy SDirectorJun 01 '25Option Exercise0.003150315Jun 02 08:03 PM
Carges Mark TDirectorJun 01 '25Option Exercise0.003570357Jun 02 08:02 PM
Hedley Mary LynneDirectorJun 01 '25Option Exercise0.0034306,103Jun 02 08:01 PM
Hung PriscillaDirectorJun 01 '25Option Exercise0.0034304,309Jun 02 08:00 PM
Hunt NimrataDirectorJun 01 '25Option Exercise0.0034304,202Jun 02 07:59 PM
MOHR MARSHALLDirectorJun 01 '25Option Exercise0.0038504,821Jun 02 07:59 PM
Ritter GordonDirectorJun 01 '25Option Exercise0.003990797Jun 02 07:57 PM
SEKHRI PAUL JDirectorJun 01 '25Option Exercise0.00329016,669Jun 02 07:57 PM
Wallach Matthew JDirectorJun 01 '25Option Exercise0.003290105,920Jun 02 07:56 PM
Schwenger Thomas D.Pres. & Chief Customer OfficerMay 29 '25Sale268.111,150308,32424,739Jun 02 02:42 PM
Faddis JonathanSVP, Gen. Counsel, SecretaryMay 02 '25Sale236.71833197,1797,835May 05 04:31 PM
Faddis JonathanOfficerMay 02 '25Proposed Sale236.71833197,179May 02 04:19 PM
Schwenger Thomas D.Pres. & Chief Customer OfficerApr 14 '25Sale220.971,200265,16825,889Apr 15 04:49 PM
Schwenger Thomas D.OfficerApr 10 '25Proposed Sale223.294,9501,105,300Apr 10 11:03 AM
Cabral Timothy SDirectorApr 04 '25Sale216.833,882841,7345,500Apr 08 04:55 PM
Cabral Timothy SDirectorApr 04 '25Proposed Sale216.773,882841,482Apr 04 02:10 PM
Zuppas Eleni NitsaPresident & Chief of StaffApr 01 '25Option Exercise0.001,324024,103Apr 02 05:50 PM
Van Wagener BrianChief Financial OfficerApr 01 '25Option Exercise0.0082306,393Apr 02 05:49 PM
Schwenger Thomas D.Pres. & Chief Customer OfficerApr 01 '25Option Exercise0.001,909030,238Apr 02 05:48 PM
Faddis JonathanSVP, Gen. Counsel, SecretaryApr 01 '25Option Exercise0.001,12009,856Apr 02 05:46 PM
Faddis JonathanSVP, Gen. Counsel, SecretaryApr 02 '25Sale226.20787178,0198,668Apr 02 05:46 PM
DIAMOND KRISTINEChief Accounting OfficerApr 01 '25Option Exercise0.002040942Apr 02 05:45 PM
Faddis JonathanOfficerApr 02 '25Proposed Sale226.20787178,019Apr 02 04:12 PM
Carges Mark TDirectorMar 01 '25Option Exercise0.003560356Mar 03 07:17 PM
Cabral Timothy SDirectorMar 01 '25Option Exercise0.003140314Mar 03 07:16 PM
Hedley Mary LynneDirectorMar 01 '25Option Exercise0.0034205,760Mar 03 07:15 PM
Hung PriscillaDirectorMar 01 '25Option Exercise0.0034203,966Mar 03 07:14 PM
Hunt NimrataDirectorMar 01 '25Option Exercise0.0034203,859Mar 03 07:13 PM
MOHR MARSHALLDirectorMar 01 '25Option Exercise0.0038404,436Mar 03 07:12 PM
Ritter GordonDirectorMar 01 '25Option Exercise0.003980398Mar 03 07:11 PM
SEKHRI PAUL JDirectorMar 01 '25Option Exercise0.00328016,340Mar 03 07:10 PM
Wallach Matthew JDirectorMar 01 '25Option Exercise0.003280105,591Mar 03 07:08 PM